Developmental toxicity of metal chelating agents.
Chelation therapy is the basis for the treatment of metal poisoning. A number of chelating agents have been widely used since the 1950s. Since these agents can be potentially given to a metal-intoxicated pregnant woman, their intrinsic developmental toxicities are a matter of concern. While the embryo/fetal toxic effects of some chelators have been reported to occur at doses higher than those currently given in the medical treatment of metal poisoning, according to experimental data the potential use of other metal antidotes is controversial. In those cases, the benefits and risks of usage should be carefully weighed. The developmental toxicity of known chelators of clinical interest is presented here. Chelating agents were divided according to the following structurally related categories: polyaminocarboxylic acids, chelators with vicinal -SH groups, beta-mercapto-alpha-aminoacids, hydroxamic acids, ortho-hydroxycarboxylic acids, and miscellaneous agents. Since it has been demonstrated that the teratogenic potential of most chelators is, at least in part, due to induced trace element deficiencies, the advisability of mineral supplements during chelation treatment is also discussed.
Laboratory of Toxicology and Environmental Health, School of Medicine, Rovira i Virgili University, Reus, Spain.
J L
JL
Domingo
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000596:Amino Acids / Q000633:toxicity; D000818:Animals; D002614:Chelating Agents / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D008670:Metals / Q000506:poisoning; D010636:Phenols / Q000633:toxicity; D011247:Pregnancy; D013438:Sulfhydryl Compounds / Q000633:toxicity
D000596:Amino Acids; D002614:Chelating Agents; D008670:Metals; D010636:Phenols; D013438:Sulfhydryl Compounds